Rates, Predictors, and Outcomes of Portal Lymphadenectomy for Resectable Gallbladder Cancer.

Phillip M Kemp BohanAnne E O'SheaOriana V EllisRobert C ChickAlex M ClemDerek T KirbyJulia O BaderTimothy E NewhookG Travis CliftonChing-Wei D TzengDaniel W NelsonTimothy J Vreeland

Published in: Annals of surgical oncology (2021)

LND is associated with a 48% reduction in risk of death in patients with resectable non-metastatic GBC, with greatest impact in pT2-3 patients. Patients without LND have similar OS to patients with node-positive disease, highlighting the importance of LND. Underutilization of LND likely results in undertreatment of patients with undiagnosed nodal disease, which may contribute to unfavorable oncologic outcomes.

Keyphrases

end stage renal disease
ejection fraction
newly diagnosed
lymph node
chronic kidney disease
small cell lung cancer
squamous cell carcinoma
prostate cancer
prognostic factors
early stage
lymph node metastasis
adipose tissue
weight loss
sentinel lymph node